Neuronetics Inc (NASDAQ:STIM) has a beta value of 1.87 and has seen 1.46 million shares traded in the last trading session. The company, currently valued at $203.15M, closed the last trade at $5.07 per share which meant it gained $0.11 on the day or 2.22% during that session. The STIM stock price is -16.77% off its 52-week high price of $5.92 and 89.74% above the 52-week low of $0.52.
The consensus among analysts is that Neuronetics Inc (STIM) is Buy stock at the moment, with a recommendation rating of 1.50. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.12.
Neuronetics Inc (NASDAQ:STIM) trade information
Sporting 2.22% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the STIM stock price touched $5.07 or saw a rise of 14.36%. Year-to-date, Neuronetics Inc shares have moved 214.91%, while the 5-day performance has seen it change 19.29%. Over the past 30 days, the shares of Neuronetics Inc (NASDAQ:STIM) have changed 55.05%.
Wall Street analysts have a consensus price target for the stock at $8, which means that the shares’ value could jump 36.62% from current levels. The projected low price target is $8.0 while the price target rests at a high of $8.0. In that case, then, we find that the current price level is -57.79% off the targeted high while a plunge would see the stock gain -57.79% from current levels.
Neuronetics Inc (STIM) estimates and forecasts
The company’s shares have gained 516.49% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 99.43%.
4 analysts offering their estimates for the company have set an average revenue estimate of 29.07M for the current quarter. 4 have an estimated revenue figure of 36.69M for the next ending quarter. Year-ago sales stood 17.42M and 16.45M respectively for this quarter and the next, and analysts expect sales will grow by 66.89% for the current quarter and 99.43% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 2.87% over the past 5 years. Earnings growth for 2025 is a modest 77.06% while over the next 5 years, the company’s earnings are expected to increase by 61.20%.
STIM Dividends
Neuronetics Inc is expected to release its next earnings report in April this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Neuronetics Inc (NASDAQ:STIM)’s Major holders
The top two institutional holders are ARCHON CAPITAL MANAGEMENT LLC with over 2.47 million shares worth more than $4.45 million. As of 2024-06-30, ARCHON CAPITAL MANAGEMENT LLC held 8.23% of shares outstanding.
The other major institutional holder is CANNELL CAPITAL LLC, with the holding of over 2.38 million shares as of 2024-06-30. The firm’s total holdings are worth over $4.29 million and represent 7.9239% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund . As of Sep 30, 2024 , the former fund manager holds about 2.80% shares in the company for having 849.5 shares of worth $4.31 million while later fund manager owns 403.88 shares of worth $2.05 million as of Sep 30, 2024 , which makes it owner of about 1.33% of company’s outstanding stock.
